{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:49:24Z","timestamp":1764251364448},"reference-count":42,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3256","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T17:06:30Z","timestamp":1422723990000},"page":"251-259","source":"Crossref","is-referenced-by-count":9,"title":["XPD Lys751Gln Polymorphisms and the Risk of Esophageal Cancer: An Updated Meta-Analysis"],"prefix":"10.2169","volume":"54","author":[{"given":"Xu-Feng","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Renmin Hospital of Wuhan University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Renmin Hospital of Wuhan University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Fei","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Renmin Hospital of Wuhan University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ping","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Renmin Hospital of Wuhan University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Guo","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Renmin Hospital of Wuhan University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin 55: 74-108, 2005.","DOI":"10.3322\/canjclin.55.2.74"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.","DOI":"10.3322\/CA.2007.0010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lagergren J, Bergstr&ouml;m R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825-831, 1999.","DOI":"10.1056\/NEJM199903183401101"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lagergren J, Bergstr&ouml;m R, Lindgren A, et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85: 340-346, 2000.","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<340::AID-IJC8>3.0.CO;2-N"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lindblad M, Rodr&iacute;guez LA, Lagergren J, et al. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16: 285-294, 2005.","DOI":"10.1007\/s10552-004-3485-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 872-878, 2006.","DOI":"10.1158\/1055-9965.EPI-05-0860"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165: 1424-1433, 2007.","DOI":"10.1093\/aje\/kwm051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374, 2001.","DOI":"10.1038\/35077232"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ishikawa T, Zhang SS, Qin X, et al. DNA repair and cancer: lessons from mutant mouse models. Cancer Sci 95: 112-117, 2004.","DOI":"10.1111\/j.1349-7006.2004.tb03190.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yoon HH, Catalano PJ, Murphy KM, et al. Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group. BMC Cancer 11: 176, 2011.","DOI":"10.1186\/1471-2407-11-176"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ouyang FD, Yang FL, Chen HC, et al. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol 34: 2843-2848, 2013.","DOI":"10.1007\/s13277-013-0844-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mittal RD, Mandal RK. Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population. Indin J Hum Genet 18: 47-55, 2012.","DOI":"10.4103\/0971-6866.96648"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Engin AB, Karahalil B, Engin A, et al. DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastriccarcinoma. Mol Biol Rep 8: 5379-5386, 2011.","DOI":"10.1007\/s11033-011-0690-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Huang MY, Wang JY, Huang ML, et al. Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome. Int J Mol Sci 14: 4121-4134, 2013.","DOI":"10.3390\/ijms14024121"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826, 1997.","DOI":"10.7326\/0003-4819-127-9-199711010-00008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"17","unstructured":"17. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Huang CG, Liu T, Lv GD, et al. Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Mol Bil Rep 39: 709-714, 2012.","DOI":"10.1007\/s11033-011-0789-z"},{"key":"19","unstructured":"19. Wang LZ. Association of tagging SNPs in ERCC2 gene with esophageal squamous cell carcinoma in Henan Han population. Department of Epidemiology and Bioststistics College of Public Health. 2012: 17-18."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Li RZ, Sun J. Association between XPD gene polymorphisms and esophageal quamous cell carcinoma. Mol Med Rep 7: 674-678, 2013.","DOI":"10.3892\/mmr.2012.1215"},{"key":"21","unstructured":"21. Wu XB. XPD Gene polymorphisms and susceptibility to develping esophageal cancer. A thesis submitted to Zhengzhou University for the degree of Master. 2010: 30-34."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zhai XD, Mo YN, Xue XQ, et al. XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population. Bull Cancer 96: E61-E65, 2009.","DOI":"10.1684\/bdc.2009.0952"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pan J, Lin J, Izzo JG, et al. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis 30: 785-792, 2009.","DOI":"10.1093\/carcin\/bgp058"},{"key":"24","unstructured":"24. Chen MR, Chen JM, Guo P, et al. Polymorphism of DNA repair gene XPD and XRCC land its relationship with esophageal squamous cell carcinoma. Fudan University J Med Sci 35: 273-281, 2008."},{"key":"25","unstructured":"25. Zhou MR. Correlation of nucleotide excision repair gene XPC and XPD polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Hebei University for the degree of Master. 2007: 43-44."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sobti RC, Singh J, Kaur P, et al. XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squa mous cell carcinoma in a North Indian population. Cancer Genet Cytogenet 175: 91-97, 2007.","DOI":"10.1016\/j.cancergencyto.2007.01.001"},{"key":"27","unstructured":"27. Zhang WC, Yin LH, Pu YP, et al. Relaionship between polymorphisms of DNA repair genes and esophageal cancer susceptibility. Chin J Public Health 22: 557-558, 2006."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ye W, Kumar R, Bacova G, et al. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis 27: 1835-1841, 2006.","DOI":"10.1093\/carcin\/bgl017"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Yu HP, Wang XL, Sun X, et al. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet 154: 10-15, 2004.","DOI":"10.1016\/j.cancergencyto.2004.01.027"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Xing D, Qi J, Tan W, et al. Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing. Chinese Journal of Medical Genetics 20: 35-38, 2003 (in Chinese, Abstract in English).","DOI":"10.1016\/S0169-5002(02)00184-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Xing D, Tan W, Wei Q, et al. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 38: 123-129, 2002.","DOI":"10.1016\/S0169-5002(02)00184-8"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ferguson HR, Wild CP, Anderson LA, et al. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Cancer Epidemiol Biomarkers Prev 17: 736-739, 2008.","DOI":"10.1158\/1055-9965.EPI-07-2832"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Tse D, Zhai R, Zhou W, et al. Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control 19: 1077-1083, 2008.","DOI":"10.1007\/s10552-008-9171-4"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Doecke J, Zhao ZZ, Pandeya N, et al. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer 123: 174-180, 2008.","DOI":"10.1002\/ijc.23410"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Liu G, Zhou W, Yeap BY, et al. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis 28: 1254-1258, 2007.","DOI":"10.1093\/carcin\/bgm020"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Casson AG, Zheng Z, Evans SC, et al. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adeno carcinoma. Carcinogenesis 26: 1536-1541, 2005.","DOI":"10.1093\/carcin\/bgi115"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21: 551-555, 2000.","DOI":"10.1093\/carcin\/21.4.551"},{"key":"38","unstructured":"38. Horner M, Ries L, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD. [cited 2013 Nov 20]. Available online: http:\/\/seer.cancer.gov\/csr\/1975_2006\/, based on November 2008 SEER data submission, posted to the SEER web site, 2009."},{"key":"39","unstructured":"39. Berry MF. Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis 6: S289-S297, 2014."},{"key":"40","unstructured":"40. Mao YS, He J, Xue Q, et al. Nationwide speaking tour of standardized diagnosis and treatment for esophageal cancer. Clin J Gastrointest Surg 19: 801-804, 2013."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Ding DP, Ma WL, He XF, et al. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. Mol Biol Rep 39: 2533-2540, 2012.","DOI":"10.1007\/s11033-011-1005-x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Yuan L, Cui D, Zhao EJ, et al. XPD Lys751Gln polymorphism and esophageal cancer risk: A meta-analysis involving 2288 cases and 4096 controls. World J Gastroenterol 17: 2343-2348, 2011.","DOI":"10.3748\/wjg.v17.i18.2343"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T07:43:24Z","timestamp":1566287004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/3\/54_54.3256\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3256","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}